JP2017510400A5 - - Google Patents

Download PDF

Info

Publication number
JP2017510400A5
JP2017510400A5 JP2016575315A JP2016575315A JP2017510400A5 JP 2017510400 A5 JP2017510400 A5 JP 2017510400A5 JP 2016575315 A JP2016575315 A JP 2016575315A JP 2016575315 A JP2016575315 A JP 2016575315A JP 2017510400 A5 JP2017510400 A5 JP 2017510400A5
Authority
JP
Japan
Prior art keywords
item
composition
self
solution
assembling peptide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2016575315A
Other languages
English (en)
Japanese (ja)
Other versions
JP2017510400A (ja
JP6554121B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2015/019740 external-priority patent/WO2015138475A1/en
Publication of JP2017510400A publication Critical patent/JP2017510400A/ja
Publication of JP2017510400A5 publication Critical patent/JP2017510400A5/ja
Application granted granted Critical
Publication of JP6554121B2 publication Critical patent/JP6554121B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2016575315A 2014-03-10 2015-03-10 気管支閉鎖剤としての自己組織化ペプチド Expired - Fee Related JP6554121B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201461950529P 2014-03-10 2014-03-10
US61/950,529 2014-03-10
US201461953146P 2014-03-14 2014-03-14
US61/953,146 2014-03-14
PCT/US2015/019740 WO2015138475A1 (en) 2014-03-10 2015-03-10 Self-assembling peptides as bronchial obstruction agents

Publications (3)

Publication Number Publication Date
JP2017510400A JP2017510400A (ja) 2017-04-13
JP2017510400A5 true JP2017510400A5 (enExample) 2018-05-31
JP6554121B2 JP6554121B2 (ja) 2019-07-31

Family

ID=52737414

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2016575315A Expired - Fee Related JP6554121B2 (ja) 2014-03-10 2015-03-10 気管支閉鎖剤としての自己組織化ペプチド

Country Status (5)

Country Link
US (2) US20170173221A1 (enExample)
EP (1) EP3116523B1 (enExample)
JP (1) JP6554121B2 (enExample)
ES (1) ES2706492T3 (enExample)
WO (1) WO2015138475A1 (enExample)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105435211A (zh) 2008-10-06 2016-03-30 三维肽胶株式会社 组织闭塞剂
EP2869903B1 (en) 2012-07-06 2018-11-28 3-D Matrix Ltd. Fill-finish process for peptide solutions
US20160287744A1 (en) 2012-11-14 2016-10-06 3-D Matrix Ltd. Vascular embolic system
ES3037364T3 (en) 2014-03-10 2025-10-01 3 D Matrix Ltd Sterilization and filtration of peptide compositions
ES2712608T3 (es) 2014-03-10 2019-05-14 3 D Matrix Ltd Péptidos autoensamblantes para el tratamiento de las bullas pulmonares
DK3116896T3 (en) 2014-03-10 2019-03-18 3 D Matrix Ltd SELF-PREPARING PEPTIME COMPOSITIONS
WO2017120092A1 (en) * 2016-01-06 2017-07-13 3-D Matrix, Ltd. Combination compositions
CN117085140A (zh) 2017-12-15 2023-11-21 立美基股份有限公司 表面活性剂肽纳米结构及在药物递送中的用途
CN112368295B (zh) * 2018-07-03 2025-03-21 立美基股份有限公司 离子性自组装肽
CN115397454A (zh) 2020-03-31 2022-11-25 立美基股份有限公司 通过辐照对自组装肽进行灭菌
CA3188208A1 (en) * 2020-08-10 2022-02-17 Yewoo LEE Delivery of cells and tissues with self-assembling peptide hydrogel materials
JP2023537951A (ja) * 2020-08-10 2023-09-06 ジェルフォーメッド，インク． 自己組織化両親媒性ペプチドハイドロゲル
WO2022035783A2 (en) * 2020-08-10 2022-02-17 Gel4Med, Inc. Topical and parenteral use and administration of self-assembling amphiphilic peptide hydrogels

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2004508140A (ja) * 2000-09-11 2004-03-18 クロージャー　メディカル　コーポレイション 気管支閉塞法および装置
US20040242469A1 (en) * 2002-05-13 2004-12-02 Lee Richard T. Angiogenesis and cardiac tissue engineering with peptide hydrogels and related compositions and methods of use thereof
HUE037994T2 (hu) * 2006-04-25 2018-09-28 Massachusetts Inst Technology Készítmények és eljárások szennyezõ anyagok, testfolyadékok vagy más anyagok mozgásának befolyásolására és/vagy más fiziológiai állapotok befolyásolására
CN105435211A (zh) * 2008-10-06 2016-03-30 三维肽胶株式会社 组织闭塞剂
JP6034868B2 (ja) * 2011-09-02 2016-11-30 株式会社スリー・ディー・マトリックス 胸部の空気漏れ閉塞のための両親媒性ペプチド
ES2712608T3 (es) * 2014-03-10 2019-05-14 3 D Matrix Ltd Péptidos autoensamblantes para el tratamiento de las bullas pulmonares

Similar Documents

Publication Publication Date Title
JP2017513928A5 (enExample)
JP2017513927A5 (enExample)
JP6554121B2 (ja) 気管支閉鎖剤としての自己組織化ペプチド
US10952961B2 (en) Implants and constructs including hollow fibers
JP2019528320A5 (enExample)
JP2016515113A5 (enExample)
KR20110081204A (ko) 트레프로스티닐의 폐 심부 전달
JP2015129129A (ja) 肺高血圧症のための治療
RU2018136580A (ru) Цитратная соль (s)-4-((s)-3-фтор-3-(2-(5,6,7,8-тетрагидро-1,8-нафтиридин-2-ил)этил)пирролидин-1-ил)-3-(3-(2-метоксиэтокси)фенил)бутановой кислоты
Mangoni et al. A PPAR-gamma agonist attenuates pulmonary injury induced by irradiation in a murine model
JP2025515491A5 (enExample)
KR101835895B1 (ko) 목시플록사신을 귀에 도포하기 위한 방법 및 조성물
ES2774773T3 (es) Agente terapéutico para la osteoporosis
RU2020109705A (ru) Соединения и их фармацевтические композиции для применения в лечении фиброзных заболеваний
JP2019518569A5 (enExample)
Guevara et al. Porcupine quill migration in the thoracic cavity of a German shorthaired pointer
Ursella et al. The use of non-invasive ventilation in the treatment of acute cardiogenic pulmonary edema.
ES2661173T3 (es) Combinación de solución de aminoácidos y un derivado de gelatina para inhibir la absorción renal
O’Callaghan et al. Pulmonary hypertension and left heart disease: emerging concepts and treatment strategies
Calenda et al. Duration of pain after a combination of peribulbar anesthesia and local anesthetic in the ball after enucleation or evisceration: 115 cases
Vandenberg et al. 111In-labeled platelet scintigraphy and two-dimensional echocardiography for detection of left atrial appendage thrombi: Studies in a new canine model
Pitsiou et al. Successful up-front combination therapy in a patient with idiopathic pulmonary hypertension and patent foramen ovale: an alternative to epoprostenol therapy?
US10052429B2 (en) Devices and methods for lung volume reduction
Latsios et al. Substitution of ethanol with specially designed microspheres in a TASH procedure
Bergmann et al. Clinical Cases in LAA Occlusion: Indication, Techniques, Devices, Implantation